For the Inventor, By the Inventor

Enter assignee name

Daejeon, South Korea

Angiolab, Inc.

USPTO Granted Patents = 11

CIPO Patents = 2

EPO Patents = 6

Forward Citations = 31

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Min-Young Kim (11 out of 13 patents)

Byung-Young Park (4 out of 4 patents)

Chang-Hee Moon (3 out of 3 patents)

4. Eun-Kyu Park (3 out of 3 patents)

5. Kyoung-Mi Kim (3 out of 3 patents)

6. Byung Young Park (3 out of 3 patents)

7. Hee Suk Lee (3 out of 5 patents)

8. Jong Cheon Hahm (2 out of 3 patents)

9. Eun Kyu Park (2 out of 2 patents)

10. Hee-Suk Lee (2 out of 2 patents)

11. Jaewan Choi (1 out of 13 patents)

12. Ki-Hwan Bae (1 out of 1 patent)

13. Yeon-Sook Yun (1 out of 1 patent)

14. Jie-Young Song (1 out of 1 patent)

15. Young-Soo Han (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 12076359 - Pharmaceutical composition comprising a fraction ofleaf extract (2024-09-03),

2. 11224629 - Fraction of Melissa leaf extract having angiogenesis and MMP inhibitory activities, and composition comprising the same (2022-01-18),

3. 10933030 - Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization (2021-03-02),

4. 10894071 - Fraction of melissa leaf extract having angiogenesis and MMP inhibitory activities, and composition comprising the same (2021-01-19),

5. 9962331 - Composition containing horse chestnut extract (2018-05-08),

6. 9155773 - Antiobesity composition (2015-10-13),

7. 7572831 - Composition containing chalcone (2009-08-11),

8. 7485327 - [object Object] (2009-02-03),

9. 7482027 - Composition for the prevention or treatment of diseases associated with angiogenesis (2009-01-27),

10. 7413735 - Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis (2008-08-19),

11. 7163805 - Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein (2007-01-16),

Angiolab, Inc. is a leading medical technology company specializing in the development of innovative products for the diagnosis and treatment of vascular diseases. With a focus on precision and quality, Angiolab strives to improve patient outcomes and revolutionize the field of interventional cardiology. Through cutting-edge research and advanced technology, Angiolab is dedicated to providing healthcare professionals with the tools they need to deliver superior care to their patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

11 Patents

#53 in Daejeon

#966 in South Korea

#50,255 in the World

Daejeon, South Korea

Angiolab, Inc.

Forward Citations = 31

30 inventors:

Min-Young Kim (11 out of 13 patents)

Byung-Young Park (4 out of 4 patents)

Chang-Hee Moon (3 out of 3 patents)

4. Eun-Kyu Park (3 out of 3 patents)

5. Kyoung-Mi Kim (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…